Miklós Dióssy

3.5k total citations
11 papers, 400 citations indexed

About

Miklós Dióssy is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miklós Dióssy has authored 11 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miklós Dióssy's work include DNA Repair Mechanisms (7 papers), PARP inhibition in cancer therapy (7 papers) and BRCA gene mutations in cancer (2 papers). Miklós Dióssy is often cited by papers focused on DNA Repair Mechanisms (7 papers), PARP inhibition in cancer therapy (7 papers) and BRCA gene mutations in cancer (2 papers). Miklós Dióssy collaborates with scholars based in Hungary, Denmark and United States. Miklós Dióssy's co-authors include Zoltán Szállási, Zsófia Sztupinszki, István Csabai, Marcin Krzystanek, Aron C. Eklund, Nicolai J. Birkbak, Lilla Reiniger, Ali Syed, Francesco Favero and Orsolya Rusz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Miklós Dióssy

11 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miklós Dióssy Hungary 10 274 237 137 127 58 11 400
Tabari M. Baker United States 6 265 1.0× 234 1.0× 71 0.5× 98 0.8× 63 1.1× 12 406
Jessie Jeffery Australia 8 155 0.6× 346 1.5× 63 0.5× 85 0.7× 37 0.6× 8 435
Manana Elia United States 8 219 0.8× 109 0.5× 105 0.8× 145 1.1× 87 1.5× 16 340
Birgit Wackwitz Germany 5 246 0.9× 101 0.4× 91 0.7× 116 0.9× 37 0.6× 7 331
Celina Sanchez Rivers Australia 4 226 0.8× 280 1.2× 199 1.5× 141 1.1× 25 0.4× 4 488
Wenhsiang Wen United States 5 227 0.8× 213 0.9× 115 0.8× 62 0.5× 27 0.5× 8 381
Jeffrey C. Francis United Kingdom 10 190 0.7× 423 1.8× 141 1.0× 104 0.8× 58 1.0× 14 561
Maria Bisogna United States 12 157 0.6× 220 0.9× 75 0.5× 185 1.5× 76 1.3× 14 425
Michał Marek Hoppe Singapore 5 171 0.6× 165 0.7× 52 0.4× 70 0.6× 35 0.6× 9 263
Dorota Zuziak Poland 6 291 1.1× 159 0.7× 90 0.7× 181 1.4× 124 2.1× 7 436

Countries citing papers authored by Miklós Dióssy

Since Specialization
Citations

This map shows the geographic impact of Miklós Dióssy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miklós Dióssy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miklós Dióssy more than expected).

Fields of papers citing papers by Miklós Dióssy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miklós Dióssy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miklós Dióssy. The network helps show where Miklós Dióssy may publish in the future.

Co-authorship network of co-authors of Miklós Dióssy

This figure shows the co-authorship network connecting the top 25 collaborators of Miklós Dióssy. A scholar is included among the top collaborators of Miklós Dióssy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miklós Dióssy. Miklós Dióssy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Dióssy, Miklós, Zsófia Sztupinszki, Viktória Tisza, et al.. (2021). Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer. Clinical Cancer Research. 27(13). 3734–3743. 18 indexed citations
2.
Sztupinszki, Zsófia, et al.. (2021). Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer. Clinical Cancer Research. 27(20). 5681–5687. 20 indexed citations
3.
Dióssy, Miklós, Zsófia Sztupinszki, Marek Krzystanek, et al.. (2021). A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures. npj Precision Oncology. 5(1). 55–55. 19 indexed citations
4.
Plym, Anna, Miklós Dióssy, Zoltán Szállási, et al.. (2021). DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men. JNCI Cancer Spectrum. 6(1). 12 indexed citations
5.
Dióssy, Miklós, Zsófia Sztupinszki, Marek Krzystanek, et al.. (2021). Strand Orientation Bias Detector to determine the probability of FFPE sequencing artifacts. Briefings in Bioinformatics. 22(6). 13 indexed citations
6.
He, Ye, Miklós Dióssy, Christian Bowman-Colin, et al.. (2021). BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model. Proceedings of the National Academy of Sciences. 118(41). 9 indexed citations
7.
Sztupinszki, Zsófia, Miklós Dióssy, Marek Krzystanek, et al.. (2020). Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations. Clinical Cancer Research. 26(11). 2673–2680. 56 indexed citations
8.
Sztupinszki, Zsófia, Miklós Dióssy, Marek Krzystanek, et al.. (2019). Prevalence of homologous recombination deficiency (HRD)-related signatures indicates that a wider range of prostate cancer patients may benefit from PARP-inhibitor therapy. Annals of Oncology. 30. vii14–vii14. 1 indexed citations
9.
Sztupinszki, Zsófia, Miklós Dióssy, Marcin Krzystanek, et al.. (2018). Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer. npj Breast Cancer. 4(1). 16–16. 152 indexed citations
10.
Dióssy, Miklós, Lilla Reiniger, Zsófia Sztupinszki, et al.. (2018). Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors. Annals of Oncology. 29(9). 1948–1954. 53 indexed citations
11.
Birkbak, Nicolai J., Y. Li, Shailja Pathania, et al.. (2018). Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers. Annals of Oncology. 29(4). 903–909. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tabari M. Baker Breakdown of academic impact, for papers by Jessie Jeffery Breakdown of academic impact, for papers by Manana Elia Breakdown of academic impact, for papers by Birgit Wackwitz Breakdown of academic impact, for papers by Celina Sanchez Rivers Breakdown of academic impact, for papers by Wenhsiang Wen Breakdown of academic impact, for papers by Jeffrey C. Francis Breakdown of academic impact, for papers by Maria Bisogna Breakdown of academic impact, for papers by Michał Marek Hoppe Breakdown of academic impact, for papers by Dorota Zuziak
Rankless by CCL
2026